A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) (clinicaltrials.gov) - Jan 6, 2023 - P2a | N=24 | Recruiting | Sponsor: Kezar Life Sciences, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Hepatology • Immunology • Inflammation
|